Clinical Trial Update: Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for DOXIL (doxorubicin HCl liposome) in combination with Abraxane in metastatic breast cancer across Phase 1 and Phase 2; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Doxil (liposomal doxorubicin)

Snippet

Sponsor: West Virginia University | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-01-22